| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 496 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 492 | 2023 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 465 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 459 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 297 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 201 | 2024 |
| Reversible encephalopathy syndrome (PRES) in a COVID-19 patient L Princiotta Cariddi, P Tabaee Damavandi, F Carimati, P Banfi, ... Journal of Neurology 267 (11), 3157-3160, 2020 | 104 | 2020 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The lancet 403 (10440), 2057-2099, 2024 | 89 | 2024 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 88 | 2024 |
| Pharmacotherapy for Dravet syndrome: a systematic review and network meta-analysis of randomized controlled trials S Lattanzi, E Trinka, E Russo, C Del Giovane, S Matricardi, S Meletti, ... Drugs 83 (15), 1409-1424, 2023 | 23 | 2023 |
| Posterior reversible encephalopathy syndrome and COVID-19: a series of 6 cases from Lombardy, Italy A Colombo, FM Boneschi, S Beretta, N Bresolin, M Versino, L Lorusso, ... Eneurologicalsci 22, 100306, 2021 | 21 | 2021 |
| Epilepsy in cerebral amyloid angiopathy: an observational retrospective study of a large population P Tabaee Damavandi, B Storti, N Fabin, E Bianchi, C Ferrarese, ... Epilepsia 64 (2), 500-510, 2023 | 19 | 2023 |
| Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease … D Bryazka, MB Reitsma, YH Abate, AHA Abd Al Magied, A Abdelkader, ... The lancet Public health 9 (10), e729-e744, 2024 | 18 | 2024 |
| Perampanel in brain tumor-related epilepsy: a systematic review P Tabaee Damavandi, F Pasini, G Fanella, GS Cereda, G Mainini, ... Brain Sciences 13 (2), 326, 2023 | 17 | 2023 |
| Efficacy and safety of fenfluramine in epilepsy: a systematic review and meta-analysis P Tabaee Damavandi, N Fabin, R Giossi, S Matricardi, C Del Giovane, ... Neurology and therapy 12 (2), 669-686, 2023 | 13 | 2023 |
| Iatrogenic cerebral amyloid angiopathy: a multinational case series and individual patient data analysis of the literature S Pikija, J Pretnar-Oblak, S Frol, B Malojcic, T Gattringer, K Rak-Frattner, ... International Journal of Stroke 19 (3), 314-321, 2024 | 12 | 2024 |
| A real‐world comparison among third‐generation antiseizure medications: results from the COMPARE study R Roberti, G Di Gennaro, F Anzellotti, D Arnaldi, V Belcastro, S Beretta, ... Epilepsia 65 (2), 456-472, 2024 | 12 | 2024 |
| Role of magnesium in the intensive care unit and immunomodulation: a literature review F Saglietti, A Girombelli, S Marelli, F Vetrone, MG Balzanelli, ... Vaccines 11 (6), 1122, 2023 | 10 | 2023 |
| Vitamin D, chronic migraine, and extracranial pain: is there a link? Data from an observational study V Rebecchi, D Gallo, L Princiotta Cariddi, E Piantanida, ... Frontiers in Neurology 12, 651750, 2021 | 9 | 2021 |
| May migraine attack response to triptans be a predictor of the efficacy of Onabotulinum toxin-A prophylaxis? C Lovati, L Giani, C Mariotti D′ Alessandro, P Tabaee Damavandi, ... Neurological Sciences 39, 153-154, 2018 | 9 | 2018 |
